GSK-239512

DB15120InvestigationalSmall molecule

GSK-239512 is under investigation in clinical trial NCT00474513 (An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.).

Chemical structure of GSK-239512
Mechanism
Curator reviewed
Formula / weight
C23H27N3O2 · 377.488 g/mol (avg)
Code names
GSK-239512

Resolves to

Compound
UNII4I7U5C459MCAS720691-69-0ChEMBLCHEMBL3092650
Structure
InChIKeyYFRBKEVUUCQYOW-UHFFFAOYSA-NSMILESO=C1CCCN1C1=CC=C(OC2=CC3=C(CCN(CC3)C3CCC3)C=C2)N=C1
Targets
Q9Y5N1HRH3

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
30Drug interactionsStructured to mechanism, not free text
Sign in
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with GSK-239512, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In